Business Description
Rakovina Therapeutics Inc
NAICS : 541714
SIC : 3741
ISIN : CA75103L1013
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | 0.58 | |||||
Debt-to-Equity | 0.45 | |||||
Debt-to-EBITDA | -0.56 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 75.6 | |||||
9-Day RSI | 72.47 | |||||
14-Day RSI | 70.34 | |||||
6-1 Month Momentum % | -45 | |||||
12-1 Month Momentum % | -26.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.43 | |||||
Quick Ratio | 1.43 | |||||
Cash Ratio | 0.3 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.42 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -92.99 | |||||
ROA % | -61.07 | |||||
ROIC % | -68.7 | |||||
ROC (Joel Greenblatt) % | -2838.82 | |||||
ROCE % | -61.99 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 4.85 | |||||
EV-to-EBIT | -5.27 | |||||
EV-to-EBITDA | -6.39 | |||||
EV-to-FCF | -6.12 | |||||
Earnings Yield (Greenblatt) % | -18.99 | |||||
FCF Yield % | -16.6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Rakovina Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -0.04 | ||
Beta | 0.22 | ||
Volatility % | 74.43 | ||
14-Day RSI | 70.34 | ||
14-Day ATR (C$) | 0.016504 | ||
20-Day SMA (C$) | 0.118 | ||
12-1 Month Momentum % | -26.67 | ||
52-Week Range (C$) | 0.005 - 0.165 | ||
Shares Outstanding (Mil) | 90.29 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Rakovina Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Rakovina Therapeutics Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Rakovina Therapeutics Inc Frequently Asked Questions
What is Rakovina Therapeutics Inc(TSXV:RKV)'s stock price today?
When is next earnings date of Rakovina Therapeutics Inc(TSXV:RKV)?
Does Rakovina Therapeutics Inc(TSXV:RKV) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |